Mesenchymal Stem Cells Regulate Microglial Polarization via Inhibition of the HMGB1/TLR4 Signaling Pathway in Diabetic Retinopathy
Inflammation · 2024-10 · 47 (5) · 1728-1743
DOI: 10.1007/s10753-024-02005-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation, online erschienen am 16.04.2024. Verfasst von Jun Tong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Microglia, Toll-Like Receptor 4, Diabetic Retinopathy, HMGB1 Protein. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Diabetic retinopathy (DR) is recognized as the most prevalent retinal degenerative disorder. Inflammatory response usually precedes microvascular alteration and is the primary factor of diabetic retinopathy. Activated microglia express many pro-inflammatory cytokines that exacerbate retina inflammation and disruption. In the present study, we found that MSCs alleviated blood-retina barrier (BRB) breakdown in diabetic rats, as evidenced by reduced retinal edema, decreased vascular leakage, and increased occludin expression. The MSC-treated retinal microglia exhibited reduced expression of M1-phenotype markers in the diabetic rats, including inducible nitric oxide synthase (iNOS), CD16, and pro-inflammatory cytokines. On the other hand, MSCs increased the expression of M2-phenotype markers, such as arginase-1 (Arg-1), CD206, and anti-inflammatory cytokines. HMGB1/TLR4 signaling pathway is activated in DR and inhibited after MSC treatment. Consistent with in vivo evidence, MSCs drove BV2 microglia toward M2 phenotype in vitro. Overexpression of HMGB1 in microglia reversed the effects of MSC treatment, suggesting HMGB1/TLR4 pathway is necessary for MSCs' regulatory effects on microglia polarization. Collectively, MSCs exert beneficial effects on DR by polarizing microglia from M1 toward M2 phenotype via inhibiting the HMGB1/TLR4 signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Ophthalmology, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. lingyunsun@nju.edu.cn.
- Department of Ophthalmology, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. hzp19633@126.com.
- Department of Ophthalmology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. zgxie87@163.com.
Zitieren
APA
Tong, J., Yao, G., Chen, Y., Xie, H., Zheng, X., Sun, L., Huang, Z., & Xie, Z. (2024). Mesenchymal Stem Cells Regulate Microglial Polarization via Inhibition of the HMGB1/TLR4 Signaling Pathway in Diabetic Retinopathy. Inflammation, 47(5), 1728-1743. https://doi.org/10.1007/s10753-024-02005-6
Vancouver
Tong J, Yao G, Chen Y, Xie H, Zheng X, Sun L, et al. Mesenchymal Stem Cells Regulate Microglial Polarization via Inhibition of the HMGB1/TLR4 Signaling Pathway in Diabetic Retinopathy. Inflammation. 2024;47(5):1728-1743. doi:10.1007/s10753-024-02005-6
BibTeX
@article{Tong2024,
author = {Tong, Jun and Yao, Genhong and Chen, Yueqin and Xie, Hairong and Zheng, Xinyu and Sun, Lingyun and Huang, Zhenping and Xie, Zhenggao},
title = {Mesenchymal Stem Cells Regulate Microglial Polarization via Inhibition of the HMGB1/TLR4 Signaling Pathway in Diabetic Retinopathy},
journal = {Inflammation},
year = {2024},
volume = {47},
number = {5},
pages = {1728--1743},
doi = {10.1007/s10753-024-02005-6}
}
EUVIMED